Twist Bioscience Corporation - Common Stock (NQ:TWST)

Twist Bioscience Expands Express Genes Rapid Synthesis Service

January 24, 2024

Twist Bioscience Corp. (NASDAQ: TWST) Near the Top of Equities by Percentage Gain on 11/17

November 17, 2023

Via Investor Brand Network

Twist Bioscience: Q4 Earnings Insights ↗

November 17, 2023

Via Benzinga

Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion ↗

January 17, 2024

Goldman Sachs upgrades Twist Bioscience as Express Genes launch addresses SynBio division's gross margin issues. With 5-7 days gene delivery, TWST taps into a previously inaccessible market, enhancing...

Via Benzinga

Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

January 17, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Twist Bioscience to Report Fiscal 2024 First Quarter Financial Results on Friday, February 2, 2024

January 16, 2024

The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market.

Biotech Playbook: Small Caps Show Momentum Peaking During ↗

January 15, 2024

Twist Bioscience Corporation Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

January 08, 2024

Twist Bioscience Appoints Adam Laponis as Chief Financial Officer

January 05, 2024

Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use.

3 Genomics Stocks to Unlock the Future of Medicine ↗

December 19, 2023

Via InvestorPlace

Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference

December 18, 2023

While the market continues towards making new highs, it is falling short of making a breakout rally. Forthcoming CPI data and the upcoming FOMC meeting may be the catalyst for same.

Tuesday Talk: CPI Data And FOMC Meeting Hold Back Market Breakout ↗

December 12, 2023

The rally can be attributed to lower interest rates and seasonal factors from the end of Q4 through January. But recently some major biopharmaceutical deals have supported the rally.

Biotech Is Coming Back, Can The Run Last? ↗

December 11, 2023

Most stocks in ARKK’s portfolio delivered strong returns in November. These five led the way.

Five Best Performing Stocks Of The Top ETF Of November ↗

December 01, 2023

Cramer Says No To This EV Maker, But Recommends This Major Automaker Stock: It 'Goes Up And Up' ↗

Topics ETFs

November 21, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said no to Lucid Group, Inc.

Via Benzinga

S&P 500 Edges Higher; Buckle Shares Surge After Q3 Earnings ↗

November 17, 2023

U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 30 points on Friday. The Dow traded up 0.07% to 34,969.63 while the NASDAQ rose 0.21% to...

Via Benzinga

Topics Stocks

Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

November 17, 2023

Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 17, 2023

Via Benzinga

Crude Oil Rises Over 3%; BJ's Wholesale Posts Weak Sales ↗

November 17, 2023

U.S. stocks traded mostly flat midway through trading on Friday. The Dow traded up 0.01% to 34,945.78 while the NASDAQ fell 0.03% to 14,109.53. The S&P 500 also rose, gaining, 0.05% to 4,510.71.

Via Benzinga

Topics Stocks

Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On Friday ↗

November 17, 2023

U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday.

Via Benzinga

Topics Stocks

DNA-Maker Twist Bioscience Catapults 21% As 'Solid' Outlook That Tops Its Peers ↗

November 17, 2023

The company expects sales to grow 16% to 18% in fiscal year 2024, which is already underway.

Via Investor's Business Daily

Why Synthetic DNA Company Twist Bioscience Shares Are Jumping Today ↗

November 17, 2023

Twist Bioscience Corp's (NASDAQ: TWST) Q4 sales increased 16.8% Y/Y to $66.9 million,

Via Benzinga

Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2023 Financial Results

November 17, 2023

Twist Bioscience Launches Express Genes Rapid Gene Synthesis Service

November 14, 2023

Twist Bioscience to Present at 6th Annual Evercore ISI HealthCONx Conference

November 13, 2023

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

November 08, 2023

Twist Bioscience to Report Fiscal 2023 Fourth Quarter and Full Year Financial Results on Friday, November 17, 2023

November 02, 2023